findmyKOL
Clinical trialNCT02172040CompletedPhase 3Interventional

Study to Evaluate the Effect of Celecoxib on the Efficacy and Safety of Amlodipine in Subjects With Hypertension Requiring Antihypertensive Therapy

SponsorKitov Pharmaceuticals, Ltd.Enrollment152Hypertension
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United Kingdom
  • Celerion

    Belfast, Antrim, United Kingdom

  • the Medicines Evaluation Unit Ltd.

    Manchester, Greater Manchester, United Kingdom

  • Reading Clinical Research Aspect

    Ledbury, Herefordshire, United Kingdom

  • Synexus Merseyside Clinical Research Centre

    Liverpool, Merseyside, United Kingdom

  • Oldfield Surgery

    Bath, North East Somerset, United Kingdom

  • Rowden Surgery

    Chippenham, Wiltshire, United Kingdom

  • Synexus Midlands Clinical Research Centre

    Birmingham, United Kingdom

  • Synexus Scotland Clinical Research Centre

    Glasgow, United Kingdom

  • Barts Health Nhs Trust, William Harvey Heart Centre, Barts & the London, Queen Mary School of Medicine and Dentistry, Queen Mary, University of London

    London, United Kingdom

  • Reading Clinical Research Aspect

    Reading, United Kingdom

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
26 Jun 2014
Primary completion
19 Nov 2015
Completion
19 Nov 2015
Last update posted
10 Oct 2018
Registered enrollment
152
Registry id
NCT02172040

Cross-registrations

EU-CTR / CTIS (EudraCT)2013-005381-19

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.